🚀 VC round data is live in beta, check it out!
Droga Raia Valuation Multiples
Discover revenue and EBITDA valuation multiples for Droga Raia and similar public comparables like Alibaba Health, BrightSpring Health, Tsuruha Holdings, MatsukiyoCocokara and more.
Droga Raia Overview
About Droga Raia
Raia Drogasil SA is a large retail drug store operator in Brazil. The company is engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines. Its brands include Impulso, Amplimed, HealthBit, Stix, 4Bio, Drogasil, Raia and others.
Founded
2011
HQ
Employees
64.8K
Website
Sectors
Financials (LTM)
EV
$10B
Droga Raia Financials
Droga Raia reported last 12-month revenue of $9B and EBITDA of $705M.
In the same LTM period, Droga Raia generated $3B in gross profit, $705M in EBITDA, and $290M in net income.
Revenue (LTM)
Droga Raia P&L
In the most recent fiscal year, Droga Raia reported revenue of $9B and EBITDA of $716M.
Droga Raia expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $9B | XXX | $9B | XXX | XXX | XXX |
| Gross Profit | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Margin | 30% | XXX | 29% | XXX | XXX | XXX |
| EBITDA | $705M | XXX | $716M | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 6% | XXX | XXX | XXX |
| Net Profit | $290M | XXX | $262M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | — | — | $674M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Droga Raia Stock Performance
Droga Raia has current market cap of $8B, and enterprise value of $10B.
Market Cap Evolution
Droga Raia's stock price is $4.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $10B | $8B | -0.1% | XXX | XXX | XXX | $0.15 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDroga Raia Valuation Multiples
Droga Raia trades at 1.1x EV/Revenue multiple, and 13.6x EV/EBITDA.
EV / Revenue (LTM)
Droga Raia Financial Valuation Multiples
As of April 28, 2026, Droga Raia has market cap of $8B and EV of $10B.
Equity research analysts estimate Droga Raia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Droga Raia has a P/E ratio of 27.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $8B | XXX | $8B | XXX | XXX | XXX |
| EV (current) | $10B | XXX | $10B | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 13.6x | XXX | 13.4x | XXX | XXX | XXX |
| EV/EBIT | 18.3x | XXX | 18.0x | XXX | XXX | XXX |
| EV/Gross Profit | 3.5x | XXX | 3.7x | XXX | XXX | XXX |
| P/E | 27.2x | XXX | 30.2x | XXX | XXX | XXX |
| EV/FCF | 78.0x | XXX | 88.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Droga Raia Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Droga Raia Margins & Growth Rates
Droga Raia's revenue in the last 12 month grew by 16%.
Droga Raia's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Droga Raia's rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Droga Raia's rule of X is 41% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Droga Raia Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 16% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 22% | XXX | 14% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 21% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 41% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 20% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 23% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Droga Raia Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Alibaba Health | XXX | XXX | XXX | XXX | XXX | XXX |
| BrightSpring Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Tsuruha Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| MatsukiyoCocokara | XXX | XXX | XXX | XXX | XXX | XXX |
| CR Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Droga Raia M&A Activity
Droga Raia acquired XXX companies to date.
Last acquisition by Droga Raia was on XXXXXXXX, XXXXX. Droga Raia acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Droga Raia
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDroga Raia Investment Activity
Droga Raia invested in XXX companies to date.
Droga Raia made its latest investment on XXXXXXXX, XXXXX. Droga Raia invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Droga Raia
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Droga Raia
| When was Droga Raia founded? | Droga Raia was founded in 2011. |
| Where is Droga Raia headquartered? | Droga Raia is headquartered in Brazil. |
| How many employees does Droga Raia have? | As of today, Droga Raia has over 64K employees. |
| Is Droga Raia publicly listed? | Yes, Droga Raia is a public company listed on B3. |
| What is the stock symbol of Droga Raia? | Droga Raia trades under RADL3 ticker. |
| When did Droga Raia go public? | Droga Raia went public in 1995. |
| Who are competitors of Droga Raia? | Droga Raia main competitors are Alibaba Health, BrightSpring Health, Tsuruha Holdings, MatsukiyoCocokara. |
| What is the current market cap of Droga Raia? | Droga Raia's current market cap is $8B. |
| What is the current revenue of Droga Raia? | Droga Raia's last 12 months revenue is $9B. |
| What is the current revenue growth of Droga Raia? | Droga Raia revenue growth (NTM/LTM) is 16%. |
| What is the current EV/Revenue multiple of Droga Raia? | Current revenue multiple of Droga Raia is 1.1x. |
| Is Droga Raia profitable? | Yes, Droga Raia is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Droga Raia? | Droga Raia's last 12 months EBITDA is $705M. |
| What is Droga Raia's EBITDA margin? | Droga Raia's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Droga Raia? | Current EBITDA multiple of Droga Raia is 13.6x. |
| What is the current FCF of Droga Raia? | Droga Raia's last 12 months FCF is $123M. |
| What is Droga Raia's FCF margin? | Droga Raia's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Droga Raia? | Current FCF multiple of Droga Raia is 78.0x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.